tyrosine kinase domain

Invivoscribe Announces Key Submission in the EU, Expanded Presence and Activity in China

San Diego, United States:  Invivoscribe, Inc., an industry pioneer in developing and commercializing diagnostic products and reagents for hematological malignancies,…

Read More »